One-year Eye-to-eye Comparison Of Wavefront-gui...

Tetracaine Versus Lidocaine Gel In Cataract Sur...

Efficacy And Visual Prognostic Factors Of Intra...

Comparison Of Keratometric And Pachymetric Para...

Pars Plana Vitrectomy For Posterior Surface Cal...

0 votes
Personalized Medicine In Diabetic Retinopathy
Author: Aniruddha Agarwal, Mohamed K Soliman, Yasir J Sepah, Diana V Do, Quan Dong Nguyen
11 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1178-7066
DOI: 10.2147/52821
Follow this publisher

Share this publication:


Abstract: Diabetes and its microvascular complications in patients poses a significant challenge and constitutes a major health problem. When it comes to manifestations in the eye, each case of diabetic retinopathy (DR) is unique, in terms of the phenotype, genotype, and, more importantly, the therapeutic response. It is therefore important to identify factors that distinguish one patient from another. Personalized therapy in DR is a new trend aimed at achieving maximum therapeutic response in patients by identifying genotypic and phenotypic factors that may result in less than optimal response to conventional therapy, and consequently, lead to poorer outcome. With advances in the identification of these genetic markers, such as gene polymorphisms and human leucocyte antigen associations, as well as development of drugs that can target their effects, the future of personalized medicine in DR is promising. In this comprehensive review, data from various studies have been analyzed to present what has been achieved in the field of pharmacogenomics thus far. An insight into future research is also provided.

Select a payment method